Table 1 Completed and ongoing trials for heart disease using ADSCs

NCT00442806 [5]

Parallel assignment, double-blind, phase I

Acute myocardial infarction

Intracoronary injection

Safety, cardiac function

48

Completed

NCT01502501

Single group assignment, open-label, phase I, phase II

Congestive heart failure

Intramyocardial/intravenous injection

6-minute walk test, LVEF, NYHA class

10

Recruiting

NCT02673164

Parallel assignment, double-blind, phase II

Heart failure

Intramyocardial injection

Safety, LVESV

138

Not recruiting

NCT00426868

Parallel assignment, double-blind, phase I

Ischemic myocardium

Intramyocardial injection

Safety, cardiac function

36

Completed

NCT01502514

Single group assignment, open-label, phase I, phase II

Congestive Heart Failure

Intramyocardial/intravenous injection

6-minute walk test, LVEF, NYHA class

10

Recruiting

NCT02387723

Single group assignment, open-label, phase I

Heart failure

Intramyocardial injection

Safety, LVESV, LVEF

10

Completed

NCT01449032

Parallel assignment, double-blind, phase II

Chronic heart failure

Intramyocardial injection

Exercise test

60

Active, not recruiting

NCT02052427 [6]

Parallel assignment, double-blind, phase II

Chronic myocardial ischemia

Intramyocardial injection

Change in Minnesota Living with Heart Failure Questionnaire

45

completed

NCT01556022 [6]

Parallel assignment, double-blind, phase II

Chronic myocardial ischemia

Intramyocardial injection

Safety, cardiac function

45

completed

NCT01709279

Single group assignment, open-label, phase I

Ischemic heart failure

Intracoronary

All cause harmful events

6

Recruiting

NCT01974128

Single group assignment, open-label, phase I, phase II

Acute myocardial infarction

Intramyocardial injection

Cardiac Improvement

10

Not recruiting

NCT01216995

Parallel assignment, double-blind, phase II

Acute myocardial infarction

Intracoronary injection

Reduction in infarct size, MACCE rates

216

completed